Skip to content

Post-examination of patients with facial nerve palsy in childhood

Post-examination of patients with facial nerve palsy in childhood

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
DRKS
Registry ID
DRKS00033340
Enrollment
50
Registered
2024-01-09
Start date
2023-12-16
Completion date
Unknown
Last updated
2025-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

peripheral facial paralysis G51.0

Interventions

Group 1: Patients who developed peripheral facial nerve palsy before the age of 18 A video meeting is arranged in which the patients are asked to perform certain facial movements (raise eyebrows, wrin

Sponsors

Universitätsklinikum, Klinik und Poliklinik für Hals-. Nasen- und Ohrenheilkunde
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: - Facial nerve palsy diagnosed by a doctor and treated at Jena University Hospital Patients who developed facial nerve palsy before the age of 18 - Written consent of the patient or legal guardian (for patients under the age of 18) to participate in the study

Exclusion criteria

Exclusion criteria: - Lack of written consent from adult patients or legal guardians to perform the examination - Patients who were at least 18 years old when the facial nerve palsy occurred

Design outcomes

Primary

MeasureTime frame
The aim of this study is to find out whether pediatric facial nerve palsy regresses completely and without side effects or whether any effects that may occur, such as asymmetries in the face or synkinesia, have so far been overlooked. This is determined by evaluating the questionnaires and by analyzing the video recordings via eFaCE and Sunnybrook.

Secondary

MeasureTime frame
The secondary objective is to determine whether asymmetries or side effects occurred less frequently during early treatment with prednisolone and whether it can be concluded from this that this therapy is also effective in children. The patients are first differentiated according to whether they received prednisolone as therapy or not. These groups are then compared with each other in order to determine any differences in the outcome of the patients.

Countries

Germany

Contacts

Public ContactGerd Fabian Volk

Universitätsklinikum Jena, Klinik und Poliklinik für Hals-. Nasen- und Ohrenheilkunde

Fabian.Volk@med.uni-jena.de03641-9-329301

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Feb 4, 2026